Sign In
Buy LNSR
$5.66
-0.0800 (-1.39%)
At Close: Jun 22, 2026
LENSAR Q1 Earnings Call Highlights
04:04pm, Friday, 08'th May 2026
LENSAR NASDAQ: LNSR executives told investors on Thursday that the company is moving past a “transaction-related holding pattern” after the termination of its planned merger, and is now refocusing
LENSAR, Inc. (LNSR) Q1 2026 Earnings Call Transcript
11:31am, Friday, 08'th May 2026
LENSAR, Inc. (LNSR) Q1 2026 Earnings Call Transcript
LENSAR® Reports First Quarter 2026 Results and Provides Business Update
07:00am, Friday, 08'th May 2026
7 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in First Quarter 2026; Backlog of 11 ALLY Systems as of March 31, 2026
LENSAR® to Report First Quarter 2026 Results on May 8, 2026
07:00am, Thursday, 30'th Apr 2026
ORLANDO, Fla., April 30, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for t
Head-To-Head Review: LENSAR (NASDAQ:LNSR) vs. Edwards Lifesciences (NYSE:EW)
01:44am, Monday, 27'th Apr 2026
LENSAR (NASDAQ: LNSR - Get Free Report) and Edwards Lifesciences (NYSE: EW - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on th
LENSAR, Inc. (LNSR) Q4 2025 Earnings Call Transcript
02:32pm, Tuesday, 31'st Mar 2026
LENSAR, Inc. (LNSR) Q4 2025 Earnings Call Transcript
LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update
06:00am, Tuesday, 31'st Mar 2026
15 ALLY Robotic Cataract Laser Systems® (“ALLY Systems”) placed in 4Q 2025; Backlog of 13 ALLY Systems pending installation as of December 31, 2025
Contrasting DexCom (NASDAQ:DXCM) and LENSAR (NASDAQ:LNSR)
02:42am, Saturday, 28'th Mar 2026
DexCom (NASDAQ: DXCM - Get Free Report) and LENSAR (NASDAQ: LNSR - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the streng
LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review
09:04am, Tuesday, 17'th Mar 2026
In March 2025, Alcon agreed to acquire the laser solutions company for $14.00 per share for an aggregate implied value of approximately $356 million.
BYND And LNSR Set The Tone Tuesday
08:33am, Tuesday, 17'th Mar 2026
Beyond Meat (BYND) and LENSAR (LNSR) are among the names driving early action Tuesday as stock futures edge lower and oil prices move higher amid ongoing Iran r
LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC
04:30pm, Monday, 16'th Mar 2026
ORLANDO, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for t
LENSAR® Provides Update on Pending Acquisition by Alcon
05:00pm, Wednesday, 25'th Feb 2026
ORLANDO, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for th
Credit Industriel ET Commercial Sells 45,117 Shares of LENSAR, Inc. $LNSR
04:28am, Monday, 16'th Feb 2026
Credit Industriel ET Commercial reduced its position in shares of LENSAR, Inc. (NASDAQ: LNSR) by 26.8% during the undefined quarter, according to the company in its most recent Form 13F filing with th
Head to Head Analysis: LENSAR (NASDAQ:LNSR) versus enVVeno Medical (NASDAQ:NVNO)
01:24am, Saturday, 07'th Feb 2026
LENSAR (NASDAQ: LNSR - Get Free Report) and enVVeno Medical (NASDAQ: NVNO - Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two companie
Comparing CardioGenics (OTCMKTS:CGNH) & LENSAR (NASDAQ:LNSR)
02:48am, Monday, 05'th Jan 2026
CardioGenics (OTCMKTS:CGNH - Get Free Report) and LENSAR (NASDAQ: LNSR - Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the s
